Patents Assigned to Beta Pharma (Shanghai) Co., Ltd.
  • Substituted 2-anilinopyrimidine derivatives as EGFR modulators
    Patent number: 11414401
    Abstract: This application discloses novel substituted 2-anilinopyrimidine derivatives, and pharmaceutically acceptable salts, solvates, prodrugs, and compositions thereof, which are useful for the treatment or prevention of diseases or medical conditions mediated by epidermal growth factor receptors (EGFRs), including but not limited to a variety of cancers.
    Type: Grant
    Filed: March 16, 2020
    Date of Patent: August 16, 2022
    Assignees: BETA PHARMA INC., BETA PHARMA (SHANGHAI) CO., LTD.
    Inventors: Jirong Peng, Michael John Costanzo, Michael Nicholas Greco, Michael Alan Green, Victoria Lynn Wilde, Don Zhang
  • SUBSTITUTED 2-ANILINOPYRIMIDINE DERIVATIVES AS EGFR MODULATORS
    Publication number: 20200216421
    Abstract: This application discloses novel substituted 2-anilinopyrimidine derivatives, and pharmaceutically acceptable salts, solvates, prodrugs, and compositions thereof, which are useful for the treatment or prevention of diseases or medical conditions mediated by epidermal growth factor receptors (EGFRs), including but not limited to a variety of cancers.
    Type: Application
    Filed: March 16, 2020
    Publication date: July 9, 2020
    Applicants: Beta Pharma, Inc., Beta Pharma (Shanghai) Co., Ltd.
    Inventors: Jirong Peng, Michael John Costanzo, Michael Nicholas Greco, Michael Alan Green, Victoria Lynn Wilde, Don Zhang
  • SUBSTITUTED 2-ANILINOPYRIMIDINE DERIVATIVES AS EGFR MODULATORS
    Publication number: 20170362203
    Abstract: This application discloses novel substituted 2-anilinopyrimidine derivatives, and pharmaceutically acceptable salts, solvates, prodrugs, and compositions thereof, which are useful for the treatment or prevention of diseases or medical conditions mediated by epidermal growth factor receptors (EGFRs), including but not limited to a variety of cancers.
    Type: Application
    Filed: December 11, 2015
    Publication date: December 21, 2017
    Applicants: Beta Pharma, Inc., Beta Pharma (Shanghai) Co., Ltd.
    Inventors: Jirong Peng, Michael John Costanzo, Michael Nicholas Greco, Michael Alan Green, Victoria Lynn Wilde, Don Zhang